Review



glut4  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Cell Signaling Technology Inc glut4
    Glut4, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 459 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+glut4/Glut4+Mouse+mAb/pm41807690-211-20-23
    Average 96 stars, based on 459 article reviews
    glut4 - by Bioz Stars, 2026-09
    96/100 stars

    Images

    Related Articles

    Incubation:

    Article Title: TNFα-CXCR1/2 partners in crime in insulin resistance conditions.
    Article Snippet: Non-specific binding sites were blocked by Blocking Buffer (Invitrogen) for 10min at RT. .. Membranes were then incubated overnight at 4 °C with the following primary antibodies, diluted in blocking buffer: anti-Akt 1:1000 (4691 s Cell Signaling Technology, Danvers, MA, USA), anti-pAkt 1:1000 (4060 s Cell Signaling Technology, Danvers, MA, USA), anti-GLUT4 1:1000 (2213 s Cell Signaling Technology, Danvers, MA, USA), anti-JNK 1:200 (9252 s Cell Signaling Technology, Danvers, MA, USA), anti-PPARα 1:250, anti-pJNK 1:200 (9255 s Cell Signaling Technology, Danvers, MA, USA), and conjugated Actin 1:20000 (5125S, Cell Signaling Technology, Danvers, MA, USA). ..

    Article Title: Fecal microbiota transplantation derived from mild cognitive impairment individuals impairs cerebral glucose uptake and cognitive function in wild-type mice: Bacteroidetes and TXNIP-GLUT signaling pathway
    Article Snippet: .. The anti-GLUT1 (1:50000, ab115730, Abcam), anti-GLUT3 (1:1000, ab191071, Abcam), anti-GLUT4 (1:1000, 2213S, CST), and anti-TXNIP (1:1000, K0205–3, Medical & Biological Laboratories) primary antibodies were incubated overnight, followed by species-matched secondary antibodies. .. Membranes were imaged using Image System Fusion FX (Vilber Lourmat Co., Ltd., Paris, France).

    Article Title: TNFα-CXCR1/2 partners in crime in insulin resistance conditions
    Article Snippet: Non-specific binding sites were blocked by Blocking Buffer (Invitrogen) for 10 min at RT. .. Membranes were then incubated overnight at 4 °C with the following primary antibodies, diluted in blocking buffer: anti-Akt 1:1000 (4691 s Cell Signaling Technology, Danvers, MA, USA), anti-pAkt 1:1000 (4060 s Cell Signaling Technology, Danvers, MA, USA), anti-GLUT4 1:1000 (2213 s Cell Signaling Technology, Danvers, MA, USA), anti-JNK 1:200 (9252 s Cell Signaling Technology, Danvers, MA, USA), anti-PPARα 1:250, anti-pJNK 1:200 (9255 s Cell Signaling Technology, Danvers, MA, USA), and conjugated Actin 1:20000 (5125S, Cell Signaling Technology, Danvers, MA, USA). ..

    Article Title: Fecal microbiota transplantation derived from mild cognitive impairment individuals impairs cerebral glucose uptake and cognitive function in wild-type mice: Bacteroidetes and TXNIP-GLUT signaling pathway.
    Article Snippet: .. The anti-GLUT1 (1:50000, ab115730, Abcam), anti-GLUT3 (1:1000, ab191071, Abcam), anti-GLUT4 (1:1000, 2213S, CST), and anti-TXNIP (1:1000, K0205–3, Medical & Biological Laboratories) primary antibodies were incubated overnight, followed by species-matched secondary antibodies. .. Membranes were imaged using Image System Fusion FX (Vilber Lourmat Co., Ltd., Paris, France).

    Blocking Assay:

    Article Title: TNFα-CXCR1/2 partners in crime in insulin resistance conditions.
    Article Snippet: Non-specific binding sites were blocked by Blocking Buffer (Invitrogen) for 10min at RT. .. Membranes were then incubated overnight at 4 °C with the following primary antibodies, diluted in blocking buffer: anti-Akt 1:1000 (4691 s Cell Signaling Technology, Danvers, MA, USA), anti-pAkt 1:1000 (4060 s Cell Signaling Technology, Danvers, MA, USA), anti-GLUT4 1:1000 (2213 s Cell Signaling Technology, Danvers, MA, USA), anti-JNK 1:200 (9252 s Cell Signaling Technology, Danvers, MA, USA), anti-PPARα 1:250, anti-pJNK 1:200 (9255 s Cell Signaling Technology, Danvers, MA, USA), and conjugated Actin 1:20000 (5125S, Cell Signaling Technology, Danvers, MA, USA). ..

    Article Title: TNFα-CXCR1/2 partners in crime in insulin resistance conditions
    Article Snippet: Non-specific binding sites were blocked by Blocking Buffer (Invitrogen) for 10 min at RT. .. Membranes were then incubated overnight at 4 °C with the following primary antibodies, diluted in blocking buffer: anti-Akt 1:1000 (4691 s Cell Signaling Technology, Danvers, MA, USA), anti-pAkt 1:1000 (4060 s Cell Signaling Technology, Danvers, MA, USA), anti-GLUT4 1:1000 (2213 s Cell Signaling Technology, Danvers, MA, USA), anti-JNK 1:200 (9252 s Cell Signaling Technology, Danvers, MA, USA), anti-PPARα 1:250, anti-pJNK 1:200 (9255 s Cell Signaling Technology, Danvers, MA, USA), and conjugated Actin 1:20000 (5125S, Cell Signaling Technology, Danvers, MA, USA). ..



    Similar Products

    86
    Huabio Inc glut4
    Glut4, supplied by Huabio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+glut4/anti+glut1/pm42271349-74-59-61
    Average 86 stars, based on 1 article reviews
    glut4 - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    95
    Santa Cruz Biotechnology glut4
    Analysis of multiple adipocyte PM proteomic datasets. A , schematic of the insulin treatments and PM isolation methods in different PM proteomic datasets. DS, datasets. LC-MS/MS, liquid chromatography-tandem mass spectrometry. GO-CC, Gene Ontology cellular component. B , UpSet plot showing the overlap of insulin-regulated ( p < 0.05) integral PM proteins across PM proteomic datasets with ≥3 biological replicates. C , Heatmap of 37 integral PM proteins identified by meta-analysis as significantly insulin-regulated and detected in ≥3 datasets. Values represent log 2 insulin-over-basal fold change (FOB); ND, not detected. D , insulin responsiveness of IRAP, <t>GLUT4,</t> TFR, KCC1, and PIT2 across nine datasets. E , Spearman correlation between IRAP, GLUT4, TFR, KCC1, and PIT2 mRNA expression in subcutaneous adipose tissue and metabolic clinical features. Figure generated from adiposetissue.org using data from ( , , , , , , , , , , , , , , , , , , , , ) (∗ pFDR < 0.05, ∗∗ pFDR < 0.01, ∗∗∗pFDR < 0.001). BMI, body mass index; circ, circulating; CRP, C-reactive protein; HDL, high-density lipoprotein; HOMA-IR, homeostatic model assessment for insulin resistance; iso, isoproterenol; LDL, low-density lipoprotein; LEP, leptin; TG, triglycerides; WAT, white adipose tissue; WHR, waist-to-hip ratio. PM, plasma membrane; IRAP, insulin-regulated aminopeptidase; TFR, transferrin receptor; PIT2, sodium-dependent phosphate transporter 2; GLUT4, glucose transporter 4; pFDR, positive false discovery rate.
    Glut4, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+glut4/Glut4/pmc12993322-359-29-42
    Average 95 stars, based on 1 article reviews
    glut4 - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    86
    Alpha Diagnostics anti glut4 antibody
    Effect of PIN overexpression on glucose uptake and <t>GLUT4</t> translocation in L6 and primary muscle cells. ( A ) Western blotting analysis of PIN overexpression after transfection with PIN cDNA (PIN) or the empty vector (C) in L6 myocytes. ( B ) Effects of PIN overexpression on glucose uptake in L6 myocytes with or without 100 nM insulin. ( C ) Effects of PIN overexpression on glucose uptake in primary myotubes with or without 100 nM insulin. ( D ) Western blotting analysis of GLUT1 expression after transfection with PIN cDNA (PIN) or the empty vector (C) in L6 myocytes. ( E ) Western blotting analysis of GLUT4 expression after transfection with PIN cDNA (PIN) or the empty vector (C) in L6 myocytes. ( F ) Colorimetric immunoassay measuring GLUT4 translocation after PIN overexpression in L6 myocytes with or without 100 nM insulin. * p < 0.05; ** p < 0.01; and *** p < 0.001.
    Anti Glut4 Antibody, supplied by Alpha Diagnostics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+glut4/anti+glut4/pmc13114162-62-13-25
    Average 86 stars, based on 1 article reviews
    anti glut4 antibody - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    96
    Santa Cruz Biotechnology mouse anti glut4
    Effect of PIN overexpression on glucose uptake and <t>GLUT4</t> translocation in L6 and primary muscle cells. ( A ) Western blotting analysis of PIN overexpression after transfection with PIN cDNA (PIN) or the empty vector (C) in L6 myocytes. ( B ) Effects of PIN overexpression on glucose uptake in L6 myocytes with or without 100 nM insulin. ( C ) Effects of PIN overexpression on glucose uptake in primary myotubes with or without 100 nM insulin. ( D ) Western blotting analysis of GLUT1 expression after transfection with PIN cDNA (PIN) or the empty vector (C) in L6 myocytes. ( E ) Western blotting analysis of GLUT4 expression after transfection with PIN cDNA (PIN) or the empty vector (C) in L6 myocytes. ( F ) Colorimetric immunoassay measuring GLUT4 translocation after PIN overexpression in L6 myocytes with or without 100 nM insulin. * p < 0.05; ** p < 0.01; and *** p < 0.001.
    Mouse Anti Glut4, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+glut4/Glut4+Antibody/pm41912478-90-84-88
    Average 96 stars, based on 1 article reviews
    mouse anti glut4 - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    96
    Proteintech glut4
    Effect of PIN overexpression on glucose uptake and <t>GLUT4</t> translocation in L6 and primary muscle cells. ( A ) Western blotting analysis of PIN overexpression after transfection with PIN cDNA (PIN) or the empty vector (C) in L6 myocytes. ( B ) Effects of PIN overexpression on glucose uptake in L6 myocytes with or without 100 nM insulin. ( C ) Effects of PIN overexpression on glucose uptake in primary myotubes with or without 100 nM insulin. ( D ) Western blotting analysis of GLUT1 expression after transfection with PIN cDNA (PIN) or the empty vector (C) in L6 myocytes. ( E ) Western blotting analysis of GLUT4 expression after transfection with PIN cDNA (PIN) or the empty vector (C) in L6 myocytes. ( F ) Colorimetric immunoassay measuring GLUT4 translocation after PIN overexpression in L6 myocytes with or without 100 nM insulin. * p < 0.05; ** p < 0.01; and *** p < 0.001.
    Glut4, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+glut4/GLUT4+Antibody/pm41900835-143-61-63
    Average 96 stars, based on 1 article reviews
    glut4 - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc glut4
    Effect of PIN overexpression on glucose uptake and <t>GLUT4</t> translocation in L6 and primary muscle cells. ( A ) Western blotting analysis of PIN overexpression after transfection with PIN cDNA (PIN) or the empty vector (C) in L6 myocytes. ( B ) Effects of PIN overexpression on glucose uptake in L6 myocytes with or without 100 nM insulin. ( C ) Effects of PIN overexpression on glucose uptake in primary myotubes with or without 100 nM insulin. ( D ) Western blotting analysis of GLUT1 expression after transfection with PIN cDNA (PIN) or the empty vector (C) in L6 myocytes. ( E ) Western blotting analysis of GLUT4 expression after transfection with PIN cDNA (PIN) or the empty vector (C) in L6 myocytes. ( F ) Colorimetric immunoassay measuring GLUT4 translocation after PIN overexpression in L6 myocytes with or without 100 nM insulin. * p < 0.05; ** p < 0.01; and *** p < 0.001.
    Glut4, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+glut4/Glut4+Mouse+mAb/pm41807690-211-20-23
    Average 96 stars, based on 1 article reviews
    glut4 - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    94
    Boster Bio glut4
    Effect of PIN overexpression on glucose uptake and <t>GLUT4</t> translocation in L6 and primary muscle cells. ( A ) Western blotting analysis of PIN overexpression after transfection with PIN cDNA (PIN) or the empty vector (C) in L6 myocytes. ( B ) Effects of PIN overexpression on glucose uptake in L6 myocytes with or without 100 nM insulin. ( C ) Effects of PIN overexpression on glucose uptake in primary myotubes with or without 100 nM insulin. ( D ) Western blotting analysis of GLUT1 expression after transfection with PIN cDNA (PIN) or the empty vector (C) in L6 myocytes. ( E ) Western blotting analysis of GLUT4 expression after transfection with PIN cDNA (PIN) or the empty vector (C) in L6 myocytes. ( F ) Colorimetric immunoassay measuring GLUT4 translocation after PIN overexpression in L6 myocytes with or without 100 nM insulin. * p < 0.05; ** p < 0.01; and *** p < 0.001.
    Glut4, supplied by Boster Bio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+glut4/Anti-Glucose+Transporter+GLUT4%2FSLC2A4+Antibody+Picoband/pmc12995679-81-58-62
    Average 94 stars, based on 1 article reviews
    glut4 - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    96
    Proteintech plin5
    Effect of PIN overexpression on glucose uptake and <t>GLUT4</t> translocation in L6 and primary muscle cells. ( A ) Western blotting analysis of PIN overexpression after transfection with PIN cDNA (PIN) or the empty vector (C) in L6 myocytes. ( B ) Effects of PIN overexpression on glucose uptake in L6 myocytes with or without 100 nM insulin. ( C ) Effects of PIN overexpression on glucose uptake in primary myotubes with or without 100 nM insulin. ( D ) Western blotting analysis of GLUT1 expression after transfection with PIN cDNA (PIN) or the empty vector (C) in L6 myocytes. ( E ) Western blotting analysis of GLUT4 expression after transfection with PIN cDNA (PIN) or the empty vector (C) in L6 myocytes. ( F ) Colorimetric immunoassay measuring GLUT4 translocation after PIN overexpression in L6 myocytes with or without 100 nM insulin. * p < 0.05; ** p < 0.01; and *** p < 0.001.
    Plin5, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+glut4/GLUT4+Antibody/pm41780607-137-40-41
    Average 96 stars, based on 1 article reviews
    plin5 - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    Image Search Results


    Analysis of multiple adipocyte PM proteomic datasets. A , schematic of the insulin treatments and PM isolation methods in different PM proteomic datasets. DS, datasets. LC-MS/MS, liquid chromatography-tandem mass spectrometry. GO-CC, Gene Ontology cellular component. B , UpSet plot showing the overlap of insulin-regulated ( p < 0.05) integral PM proteins across PM proteomic datasets with ≥3 biological replicates. C , Heatmap of 37 integral PM proteins identified by meta-analysis as significantly insulin-regulated and detected in ≥3 datasets. Values represent log 2 insulin-over-basal fold change (FOB); ND, not detected. D , insulin responsiveness of IRAP, GLUT4, TFR, KCC1, and PIT2 across nine datasets. E , Spearman correlation between IRAP, GLUT4, TFR, KCC1, and PIT2 mRNA expression in subcutaneous adipose tissue and metabolic clinical features. Figure generated from adiposetissue.org using data from ( , , , , , , , , , , , , , , , , , , , , ) (∗ pFDR < 0.05, ∗∗ pFDR < 0.01, ∗∗∗pFDR < 0.001). BMI, body mass index; circ, circulating; CRP, C-reactive protein; HDL, high-density lipoprotein; HOMA-IR, homeostatic model assessment for insulin resistance; iso, isoproterenol; LDL, low-density lipoprotein; LEP, leptin; TG, triglycerides; WAT, white adipose tissue; WHR, waist-to-hip ratio. PM, plasma membrane; IRAP, insulin-regulated aminopeptidase; TFR, transferrin receptor; PIT2, sodium-dependent phosphate transporter 2; GLUT4, glucose transporter 4; pFDR, positive false discovery rate.

    Journal: The Journal of Biological Chemistry

    Article Title: Integrated analysis of the adipocyte plasma membrane proteome reveals KCC1 and PIT2 as novel insulin-responsive transporters

    doi: 10.1016/j.jbc.2026.111282

    Figure Lengend Snippet: Analysis of multiple adipocyte PM proteomic datasets. A , schematic of the insulin treatments and PM isolation methods in different PM proteomic datasets. DS, datasets. LC-MS/MS, liquid chromatography-tandem mass spectrometry. GO-CC, Gene Ontology cellular component. B , UpSet plot showing the overlap of insulin-regulated ( p < 0.05) integral PM proteins across PM proteomic datasets with ≥3 biological replicates. C , Heatmap of 37 integral PM proteins identified by meta-analysis as significantly insulin-regulated and detected in ≥3 datasets. Values represent log 2 insulin-over-basal fold change (FOB); ND, not detected. D , insulin responsiveness of IRAP, GLUT4, TFR, KCC1, and PIT2 across nine datasets. E , Spearman correlation between IRAP, GLUT4, TFR, KCC1, and PIT2 mRNA expression in subcutaneous adipose tissue and metabolic clinical features. Figure generated from adiposetissue.org using data from ( , , , , , , , , , , , , , , , , , , , , ) (∗ pFDR < 0.05, ∗∗ pFDR < 0.01, ∗∗∗pFDR < 0.001). BMI, body mass index; circ, circulating; CRP, C-reactive protein; HDL, high-density lipoprotein; HOMA-IR, homeostatic model assessment for insulin resistance; iso, isoproterenol; LDL, low-density lipoprotein; LEP, leptin; TG, triglycerides; WAT, white adipose tissue; WHR, waist-to-hip ratio. PM, plasma membrane; IRAP, insulin-regulated aminopeptidase; TFR, transferrin receptor; PIT2, sodium-dependent phosphate transporter 2; GLUT4, glucose transporter 4; pFDR, positive false discovery rate.

    Article Snippet: Immunoblotting was performed using primary antibodies pan-AKT (Cell Signaling Technology, Cat. #2920), phospho-AKT (Thr308) (Cell Signaling Technology, Cat. #13038), SLC20A2 (PIT2) (Proteintech, Cat. #12820-1-AP), SLC12A4 (KCC1) (Proteintech, Cat. #15927-1-AP), GLUT4 (rabbit polyclonal antibody generated in-house), Caveolin 1 (CAV1) (Abcam, Cat. #ab17052), 14-3-3 (Santa Cruz Biotechnology, Cat. #sc-629), and either infrared dye 700- or 800-conjugated secondary antibodies (Thermo Fisher Scientific, Cat. #A32735 or A21036).

    Techniques: Isolation, Liquid Chromatography with Mass Spectroscopy, Liquid Chromatography, Mass Spectrometry, Expressing, Generated, Clinical Proteomics, Membrane

    KCC1 and PIT2 exhibit insulin dose-dependent PM recruitment. A , 3T3L1 adipocytes electroporated with either HA-GLUT4-mRuby3 or KCC1-mStayGold were stimulated with different insulin doses (0.01–10 nM). PM recruitment was assessed by TIRF microscopy. Representative images for three independent experiments are presented (the scale bar represents 5 μm). Bas, basal condition (0.01 nM insulin). Ins, insulin stimulation. B , quantification of panel A . FOB, insulin-over-basal fold change. C and E , 3T3L1 adipocytes electroporated with either HA-GLUT4-mRuby3 ( C ) or PIT2-HA ( E ) were stimulated with different insulin doses (0.01–100 nM). PM recruitment was assessed by immunofluorescence staining and confocal microscopy. Representative images for two to three independent experiments are presented (the scale bar represents 20 μm). D , quantification of panels C and E . F , SGBS adipocytes stimulated with 0 or 10 nM insulin were fractionated to enrich PM proteins. Whole-cell lysates (WCL) and PM fractions were immunoblotted with the indicated antibodies. 14-3-3 and caveolin-1 (CAV1) served as loading controls for WCL and PM fractions, respectively. Representative blots from three independent experiments are shown. G , quantification of panel F , statistical analysis was performed by one-way ANOVA with Dunnett’s post hoc ; ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001 (n = 2–3 independent biological replicates). In ( B and D ), p values were compared to basal (0.01 nM insulin); in ( G ), p values were compared to GLUT4. PM, plasma membrane; TIRF, total internal reflection fluorescence; SGBS, Simpson–Golabi–Behmel syndrome; PIT2, sodium-dependent phosphate transporter 2; GLUT4, glucose transporter 4.

    Journal: The Journal of Biological Chemistry

    Article Title: Integrated analysis of the adipocyte plasma membrane proteome reveals KCC1 and PIT2 as novel insulin-responsive transporters

    doi: 10.1016/j.jbc.2026.111282

    Figure Lengend Snippet: KCC1 and PIT2 exhibit insulin dose-dependent PM recruitment. A , 3T3L1 adipocytes electroporated with either HA-GLUT4-mRuby3 or KCC1-mStayGold were stimulated with different insulin doses (0.01–10 nM). PM recruitment was assessed by TIRF microscopy. Representative images for three independent experiments are presented (the scale bar represents 5 μm). Bas, basal condition (0.01 nM insulin). Ins, insulin stimulation. B , quantification of panel A . FOB, insulin-over-basal fold change. C and E , 3T3L1 adipocytes electroporated with either HA-GLUT4-mRuby3 ( C ) or PIT2-HA ( E ) were stimulated with different insulin doses (0.01–100 nM). PM recruitment was assessed by immunofluorescence staining and confocal microscopy. Representative images for two to three independent experiments are presented (the scale bar represents 20 μm). D , quantification of panels C and E . F , SGBS adipocytes stimulated with 0 or 10 nM insulin were fractionated to enrich PM proteins. Whole-cell lysates (WCL) and PM fractions were immunoblotted with the indicated antibodies. 14-3-3 and caveolin-1 (CAV1) served as loading controls for WCL and PM fractions, respectively. Representative blots from three independent experiments are shown. G , quantification of panel F , statistical analysis was performed by one-way ANOVA with Dunnett’s post hoc ; ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001 (n = 2–3 independent biological replicates). In ( B and D ), p values were compared to basal (0.01 nM insulin); in ( G ), p values were compared to GLUT4. PM, plasma membrane; TIRF, total internal reflection fluorescence; SGBS, Simpson–Golabi–Behmel syndrome; PIT2, sodium-dependent phosphate transporter 2; GLUT4, glucose transporter 4.

    Article Snippet: Immunoblotting was performed using primary antibodies pan-AKT (Cell Signaling Technology, Cat. #2920), phospho-AKT (Thr308) (Cell Signaling Technology, Cat. #13038), SLC20A2 (PIT2) (Proteintech, Cat. #12820-1-AP), SLC12A4 (KCC1) (Proteintech, Cat. #15927-1-AP), GLUT4 (rabbit polyclonal antibody generated in-house), Caveolin 1 (CAV1) (Abcam, Cat. #ab17052), 14-3-3 (Santa Cruz Biotechnology, Cat. #sc-629), and either infrared dye 700- or 800-conjugated secondary antibodies (Thermo Fisher Scientific, Cat. #A32735 or A21036).

    Techniques: Microscopy, Immunofluorescence, Staining, Confocal Microscopy, Clinical Proteomics, Membrane, Fluorescence

    Insulin-stimulated translocation of KCC1 and PIT2 to the PM requires PI3K-AKT signaling. A , schematic of the proximal insulin signaling pathway. IRS, insulin receptor substrates. PI3K, class I phosphoinositide 3-kinase. AKT, protein kinase B. B and D , 3T3-L1 adipocytes were pretreated for 10 min with 10 μM DMSO (vehicle; Ctrl), the PI3K inhibitor GDC-0941 (PI3Ki) ( B ), or the AKT inhibitor MK-2206 (AKTi) ( D ), then stimulated with 1 nM insulin. Cell lysates were immunoblotted with the indicated antibodies; 14-3-3 served as a loading control. Representative blots from three to four independent experiments are shown. C , quantification of panel B . E , quantification of panel D . F – H , 3T3L1 adipocytes electroporated with either HA-GLUT4-mRuby3 ( F and H ) or KCC1-mStayGold ( G and H ) were treated as in ( B and D ), and PM recruitment was assessed by TIRF microscopy. I , 3T3L1 adipocytes electroporated with either HA-GLUT4-mRuby3 or PIT2-HA were treated as in ( B and D ), and PM recruitment was assessed by immunofluorescence staining and confocal microscopy. Statistical analysis was performed by one-way ANOVA with Tukey’s post hoc ; ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001 (n = 2–8 independent biological replicates). PM, plasma membrane; TIRF, total internal reflection fluorescence; PI3K, phosphoinositide 3-kinase; DMSO, dimethyl sulfoxide; KCC1, potassium-chloride cotransporter; PIT2, sodium-dependent phosphate transporter 2; GLUT4, glucose transporter 4.

    Journal: The Journal of Biological Chemistry

    Article Title: Integrated analysis of the adipocyte plasma membrane proteome reveals KCC1 and PIT2 as novel insulin-responsive transporters

    doi: 10.1016/j.jbc.2026.111282

    Figure Lengend Snippet: Insulin-stimulated translocation of KCC1 and PIT2 to the PM requires PI3K-AKT signaling. A , schematic of the proximal insulin signaling pathway. IRS, insulin receptor substrates. PI3K, class I phosphoinositide 3-kinase. AKT, protein kinase B. B and D , 3T3-L1 adipocytes were pretreated for 10 min with 10 μM DMSO (vehicle; Ctrl), the PI3K inhibitor GDC-0941 (PI3Ki) ( B ), or the AKT inhibitor MK-2206 (AKTi) ( D ), then stimulated with 1 nM insulin. Cell lysates were immunoblotted with the indicated antibodies; 14-3-3 served as a loading control. Representative blots from three to four independent experiments are shown. C , quantification of panel B . E , quantification of panel D . F – H , 3T3L1 adipocytes electroporated with either HA-GLUT4-mRuby3 ( F and H ) or KCC1-mStayGold ( G and H ) were treated as in ( B and D ), and PM recruitment was assessed by TIRF microscopy. I , 3T3L1 adipocytes electroporated with either HA-GLUT4-mRuby3 or PIT2-HA were treated as in ( B and D ), and PM recruitment was assessed by immunofluorescence staining and confocal microscopy. Statistical analysis was performed by one-way ANOVA with Tukey’s post hoc ; ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001 (n = 2–8 independent biological replicates). PM, plasma membrane; TIRF, total internal reflection fluorescence; PI3K, phosphoinositide 3-kinase; DMSO, dimethyl sulfoxide; KCC1, potassium-chloride cotransporter; PIT2, sodium-dependent phosphate transporter 2; GLUT4, glucose transporter 4.

    Article Snippet: Immunoblotting was performed using primary antibodies pan-AKT (Cell Signaling Technology, Cat. #2920), phospho-AKT (Thr308) (Cell Signaling Technology, Cat. #13038), SLC20A2 (PIT2) (Proteintech, Cat. #12820-1-AP), SLC12A4 (KCC1) (Proteintech, Cat. #15927-1-AP), GLUT4 (rabbit polyclonal antibody generated in-house), Caveolin 1 (CAV1) (Abcam, Cat. #ab17052), 14-3-3 (Santa Cruz Biotechnology, Cat. #sc-629), and either infrared dye 700- or 800-conjugated secondary antibodies (Thermo Fisher Scientific, Cat. #A32735 or A21036).

    Techniques: Translocation Assay, Control, Microscopy, Immunofluorescence, Staining, Confocal Microscopy, Clinical Proteomics, Membrane, Fluorescence

    Colocalization of KCC1/PIT2 with GLUT4 and TFR in unstimulated 3T3-L1 adipocytes. A and E , cells electroporated with either KCC1-mStayGold ( A ), or PIT2-HA ( E ) ( cyan ) were fixed, permeabilized, stained for nuclei ( gray ), GLUT4 ( yellow ), and TFR ( magenta ), and imaged using confocal microscopy. Representative images from three independent experiments are shown (the scale bar represents 5 μm). B and F , quantification of panels A and E . C and G , cells were fixed, permeabilized, stained for nuclei ( gray ), GLUT4 ( yellow ), TFR ( magenta ), and KCC1 ( C ) or PIT2 ( G ) ( cyan ), and imaged using confocal microscopy. Representative images from three independent experiments are shown (the scale bar represents 5 μm). D and H , quantification of panels C and G , quantitative analysis includes (i) percentage of each protein volume above threshold colocalized with GLUT4; (ii) percentage of GLUT4-positive volume colocalized with each protein; (iii) percentage of each protein volume colocalized with TFR; and (iv) percentage of TFR-positive volume colocalized with each protein. Statistical analysis was performed by one-way ANOVA with Tukey’s post hoc test (n = 3 independent biological replicates). TFR, transferrin receptor; KCC1, potassium-chloride cotransporter; PIT2, sodium-dependent phosphate transporter 2; GLUT4, glucose transporter 4.

    Journal: The Journal of Biological Chemistry

    Article Title: Integrated analysis of the adipocyte plasma membrane proteome reveals KCC1 and PIT2 as novel insulin-responsive transporters

    doi: 10.1016/j.jbc.2026.111282

    Figure Lengend Snippet: Colocalization of KCC1/PIT2 with GLUT4 and TFR in unstimulated 3T3-L1 adipocytes. A and E , cells electroporated with either KCC1-mStayGold ( A ), or PIT2-HA ( E ) ( cyan ) were fixed, permeabilized, stained for nuclei ( gray ), GLUT4 ( yellow ), and TFR ( magenta ), and imaged using confocal microscopy. Representative images from three independent experiments are shown (the scale bar represents 5 μm). B and F , quantification of panels A and E . C and G , cells were fixed, permeabilized, stained for nuclei ( gray ), GLUT4 ( yellow ), TFR ( magenta ), and KCC1 ( C ) or PIT2 ( G ) ( cyan ), and imaged using confocal microscopy. Representative images from three independent experiments are shown (the scale bar represents 5 μm). D and H , quantification of panels C and G , quantitative analysis includes (i) percentage of each protein volume above threshold colocalized with GLUT4; (ii) percentage of GLUT4-positive volume colocalized with each protein; (iii) percentage of each protein volume colocalized with TFR; and (iv) percentage of TFR-positive volume colocalized with each protein. Statistical analysis was performed by one-way ANOVA with Tukey’s post hoc test (n = 3 independent biological replicates). TFR, transferrin receptor; KCC1, potassium-chloride cotransporter; PIT2, sodium-dependent phosphate transporter 2; GLUT4, glucose transporter 4.

    Article Snippet: Immunoblotting was performed using primary antibodies pan-AKT (Cell Signaling Technology, Cat. #2920), phospho-AKT (Thr308) (Cell Signaling Technology, Cat. #13038), SLC20A2 (PIT2) (Proteintech, Cat. #12820-1-AP), SLC12A4 (KCC1) (Proteintech, Cat. #15927-1-AP), GLUT4 (rabbit polyclonal antibody generated in-house), Caveolin 1 (CAV1) (Abcam, Cat. #ab17052), 14-3-3 (Santa Cruz Biotechnology, Cat. #sc-629), and either infrared dye 700- or 800-conjugated secondary antibodies (Thermo Fisher Scientific, Cat. #A32735 or A21036).

    Techniques: Staining, Confocal Microscopy

    Impaired PIT2 and KCC1 translocation to the PM in insulin resistance. A – D , endogenous PM GLUT4 ( A and B ) and PM TFR ( C and D ) in 3T3-L1 adipocytes at basal and after acute 1 nM insulin, following 24-h pretreatment with 0 nM, 1 nM, or 10 nM insulin. Ctrl, control; CI_L, 1 nM chronic insulin; CI_H, 10 nM chronic insulin. Data are shown as raw PM intensity ( A and C ) or normalized to total GLUT4/TFR abundance ( B and D ), and expressed as percentage of the acutely insulin-stimulated control. E and F , 3T3L1 adipocytes electroporated with PIT2-HA were exposed to either 0, 1, or 10 nM insulin for 24 h, followed by stimulation with 1 nM insulin. PM recruitment was assessed by immunofluorescence staining and confocal microscopy. Data are normalized to total PIT2-HA and expressed as percentage of the acutely insulin-stimulated control ( E ) or as the difference (%) between the acutely insulin-stimulated and basal PM intensities within each chronic-insulin condition ( F ). G and H , 3T3L1 adipocytes electroporated with either HA-GLUT4-mRuby3 ( G ) or KCC1-mStayGold ( H ) were stimulated with 1 nM insulin after treatment with 0, one or 10 nM insulin for 24 h. PM recruitment was captured by TIRF microscopy. Data are shown as insulin-over-basal fold change (FOB). Statistical analysis was performed by two-way ANOVA with Tukey’s post hoc test; ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗∗ p < 0.0001. For ( F ), one-way ANOVA with Tukey’s post hoc was used (n = 4–6 independent biological replicates). PM, plasma membrane; TIRF, total internal reflection fluorescence; TFR, transferrin receptor; KCC1, potassium-chloride cotransporter; PIT2, sodium-dependent phosphate transporter 2; GLUT4, glucose transporter 4.

    Journal: The Journal of Biological Chemistry

    Article Title: Integrated analysis of the adipocyte plasma membrane proteome reveals KCC1 and PIT2 as novel insulin-responsive transporters

    doi: 10.1016/j.jbc.2026.111282

    Figure Lengend Snippet: Impaired PIT2 and KCC1 translocation to the PM in insulin resistance. A – D , endogenous PM GLUT4 ( A and B ) and PM TFR ( C and D ) in 3T3-L1 adipocytes at basal and after acute 1 nM insulin, following 24-h pretreatment with 0 nM, 1 nM, or 10 nM insulin. Ctrl, control; CI_L, 1 nM chronic insulin; CI_H, 10 nM chronic insulin. Data are shown as raw PM intensity ( A and C ) or normalized to total GLUT4/TFR abundance ( B and D ), and expressed as percentage of the acutely insulin-stimulated control. E and F , 3T3L1 adipocytes electroporated with PIT2-HA were exposed to either 0, 1, or 10 nM insulin for 24 h, followed by stimulation with 1 nM insulin. PM recruitment was assessed by immunofluorescence staining and confocal microscopy. Data are normalized to total PIT2-HA and expressed as percentage of the acutely insulin-stimulated control ( E ) or as the difference (%) between the acutely insulin-stimulated and basal PM intensities within each chronic-insulin condition ( F ). G and H , 3T3L1 adipocytes electroporated with either HA-GLUT4-mRuby3 ( G ) or KCC1-mStayGold ( H ) were stimulated with 1 nM insulin after treatment with 0, one or 10 nM insulin for 24 h. PM recruitment was captured by TIRF microscopy. Data are shown as insulin-over-basal fold change (FOB). Statistical analysis was performed by two-way ANOVA with Tukey’s post hoc test; ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗∗ p < 0.0001. For ( F ), one-way ANOVA with Tukey’s post hoc was used (n = 4–6 independent biological replicates). PM, plasma membrane; TIRF, total internal reflection fluorescence; TFR, transferrin receptor; KCC1, potassium-chloride cotransporter; PIT2, sodium-dependent phosphate transporter 2; GLUT4, glucose transporter 4.

    Article Snippet: Immunoblotting was performed using primary antibodies pan-AKT (Cell Signaling Technology, Cat. #2920), phospho-AKT (Thr308) (Cell Signaling Technology, Cat. #13038), SLC20A2 (PIT2) (Proteintech, Cat. #12820-1-AP), SLC12A4 (KCC1) (Proteintech, Cat. #15927-1-AP), GLUT4 (rabbit polyclonal antibody generated in-house), Caveolin 1 (CAV1) (Abcam, Cat. #ab17052), 14-3-3 (Santa Cruz Biotechnology, Cat. #sc-629), and either infrared dye 700- or 800-conjugated secondary antibodies (Thermo Fisher Scientific, Cat. #A32735 or A21036).

    Techniques: Translocation Assay, Control, Immunofluorescence, Staining, Confocal Microscopy, Microscopy, Clinical Proteomics, Membrane, Fluorescence

    Chronic insulin alters the perinuclear localization of PIT2 and KCC1 under basal conditions. 3T3-L1 adipocytes were treated with 0, 1, or 10 nM insulin for 24 h, serum-starved (basal) for 2 to 3 h, then fixed, permeabilized, and stained for GLUT4 ( A and B ), PIT2 ( C and D ), KCC1 ( E and F ), or TFR ( G and H ). Cells were imaged by confocal microscopy. Representative images from three independent experiments are shown (the scale bar represents 5 μm). Ctrl, control; CI_L, 1 nM chronic insulin; CI_H, 10 nM chronic insulin. Quantification shows the ratio of summed fluorescence intensity in the perinuclear region (PNR) to total cellular intensity. Statistical analysis was performed by one-way ANOVA with Tukey’s post hoc test; ∗ p < 0.05, ∗∗ p < 0.01 (n = 3 independent biological replicates). TFR, transferrin receptor; KCC1, potassium-chloride cotransporter; PIT2, sodium-dependent phosphate transporter 2; GLUT4, glucose transporter 4.

    Journal: The Journal of Biological Chemistry

    Article Title: Integrated analysis of the adipocyte plasma membrane proteome reveals KCC1 and PIT2 as novel insulin-responsive transporters

    doi: 10.1016/j.jbc.2026.111282

    Figure Lengend Snippet: Chronic insulin alters the perinuclear localization of PIT2 and KCC1 under basal conditions. 3T3-L1 adipocytes were treated with 0, 1, or 10 nM insulin for 24 h, serum-starved (basal) for 2 to 3 h, then fixed, permeabilized, and stained for GLUT4 ( A and B ), PIT2 ( C and D ), KCC1 ( E and F ), or TFR ( G and H ). Cells were imaged by confocal microscopy. Representative images from three independent experiments are shown (the scale bar represents 5 μm). Ctrl, control; CI_L, 1 nM chronic insulin; CI_H, 10 nM chronic insulin. Quantification shows the ratio of summed fluorescence intensity in the perinuclear region (PNR) to total cellular intensity. Statistical analysis was performed by one-way ANOVA with Tukey’s post hoc test; ∗ p < 0.05, ∗∗ p < 0.01 (n = 3 independent biological replicates). TFR, transferrin receptor; KCC1, potassium-chloride cotransporter; PIT2, sodium-dependent phosphate transporter 2; GLUT4, glucose transporter 4.

    Article Snippet: Immunoblotting was performed using primary antibodies pan-AKT (Cell Signaling Technology, Cat. #2920), phospho-AKT (Thr308) (Cell Signaling Technology, Cat. #13038), SLC20A2 (PIT2) (Proteintech, Cat. #12820-1-AP), SLC12A4 (KCC1) (Proteintech, Cat. #15927-1-AP), GLUT4 (rabbit polyclonal antibody generated in-house), Caveolin 1 (CAV1) (Abcam, Cat. #ab17052), 14-3-3 (Santa Cruz Biotechnology, Cat. #sc-629), and either infrared dye 700- or 800-conjugated secondary antibodies (Thermo Fisher Scientific, Cat. #A32735 or A21036).

    Techniques: Staining, Confocal Microscopy, Control, Fluorescence

    Effect of PIN overexpression on glucose uptake and GLUT4 translocation in L6 and primary muscle cells. ( A ) Western blotting analysis of PIN overexpression after transfection with PIN cDNA (PIN) or the empty vector (C) in L6 myocytes. ( B ) Effects of PIN overexpression on glucose uptake in L6 myocytes with or without 100 nM insulin. ( C ) Effects of PIN overexpression on glucose uptake in primary myotubes with or without 100 nM insulin. ( D ) Western blotting analysis of GLUT1 expression after transfection with PIN cDNA (PIN) or the empty vector (C) in L6 myocytes. ( E ) Western blotting analysis of GLUT4 expression after transfection with PIN cDNA (PIN) or the empty vector (C) in L6 myocytes. ( F ) Colorimetric immunoassay measuring GLUT4 translocation after PIN overexpression in L6 myocytes with or without 100 nM insulin. * p < 0.05; ** p < 0.01; and *** p < 0.001.

    Journal: Antioxidants

    Article Title: PIN (Protein Inhibitor of Neuronal Nitric Oxide Synthase) Modulates Glucose Uptake Through NO-Dependent and Independent Mechanisms in Rat Muscle Cells

    doi: 10.3390/antiox15040436

    Figure Lengend Snippet: Effect of PIN overexpression on glucose uptake and GLUT4 translocation in L6 and primary muscle cells. ( A ) Western blotting analysis of PIN overexpression after transfection with PIN cDNA (PIN) or the empty vector (C) in L6 myocytes. ( B ) Effects of PIN overexpression on glucose uptake in L6 myocytes with or without 100 nM insulin. ( C ) Effects of PIN overexpression on glucose uptake in primary myotubes with or without 100 nM insulin. ( D ) Western blotting analysis of GLUT1 expression after transfection with PIN cDNA (PIN) or the empty vector (C) in L6 myocytes. ( E ) Western blotting analysis of GLUT4 expression after transfection with PIN cDNA (PIN) or the empty vector (C) in L6 myocytes. ( F ) Colorimetric immunoassay measuring GLUT4 translocation after PIN overexpression in L6 myocytes with or without 100 nM insulin. * p < 0.05; ** p < 0.01; and *** p < 0.001.

    Article Snippet: After saturation with PBS-0.4% BSA during 30 min, cells were incubated with an anti-GLUT4 antibody directed against 13 N-terminus extracellular amino acid of GLUT4 (GT42A, Alpha Diagnostic, San Antonio, TX, USA) overnight.

    Techniques: Over Expression, Translocation Assay, Western Blot, Transfection, Plasmid Preparation, Expressing

    Effect of nNOS blockade by L-NAME on glucose uptake and GLUT4 translocation in L6 and primary muscle cells. Effects of D-NAME ( A ) and L-NAME ( B ) on glucose uptake in L6 myocytes with or without 100 nM insulin. ( C ) Effects of L-NAME on glucose uptake in primary myotubes with or without 100 nM insulin. ( D ) Colorimetric immunoassay measuring GLUT4 translocation in L6 myocytes in the presence of 10 mM L-NAME with or without 100 nM insulin. ( E ) Effect of L-NAME on nNOS catalytic activity with or without 100 nM insulin. ( F ) Effects of SNP on glucose uptake in L6 myocytes with or without 100 nM insulin. * p < 0.05; ** p < 0.01; *** p < 0.001.

    Journal: Antioxidants

    Article Title: PIN (Protein Inhibitor of Neuronal Nitric Oxide Synthase) Modulates Glucose Uptake Through NO-Dependent and Independent Mechanisms in Rat Muscle Cells

    doi: 10.3390/antiox15040436

    Figure Lengend Snippet: Effect of nNOS blockade by L-NAME on glucose uptake and GLUT4 translocation in L6 and primary muscle cells. Effects of D-NAME ( A ) and L-NAME ( B ) on glucose uptake in L6 myocytes with or without 100 nM insulin. ( C ) Effects of L-NAME on glucose uptake in primary myotubes with or without 100 nM insulin. ( D ) Colorimetric immunoassay measuring GLUT4 translocation in L6 myocytes in the presence of 10 mM L-NAME with or without 100 nM insulin. ( E ) Effect of L-NAME on nNOS catalytic activity with or without 100 nM insulin. ( F ) Effects of SNP on glucose uptake in L6 myocytes with or without 100 nM insulin. * p < 0.05; ** p < 0.01; *** p < 0.001.

    Article Snippet: After saturation with PBS-0.4% BSA during 30 min, cells were incubated with an anti-GLUT4 antibody directed against 13 N-terminus extracellular amino acid of GLUT4 (GT42A, Alpha Diagnostic, San Antonio, TX, USA) overnight.

    Techniques: Translocation Assay, Activity Assay

    Effects of PIN silencing and disruption with its interacting partners on glucose uptake in L6 muscle cells. ( A ) Western blotting analysis of PIN under-expression after transfection with PIN and control (C) siRNA. ( B ) Effects of PIN silencing on glucose uptake in L6 myocytes with or without 100 nM insulin. ( C ) Western blotting analysis of GLUT1 expression after transfection with PIN and control (C) siRNA. ( D ) Western blotting analysis of GLUT4 expression after transfection with PIN and control (C) siRNA. ( E ) Colorimetric immunoassay measuring GLUT4 translocation in L6 myocytes after PIN silencing in the presence or not of 100 nM insulin. ( F ) Western blotting analysis of nNOS expression in L6 myocytes after transfection with PIN or control (C) siRNA. ( G ) Effect of PIN silencing on nNOS catalytic activity in the absence of insulin. ( H ) Coimmunoprecipitation of nNOS with PIN in the presence of the control (peptide C) versus the inhibitory peptide (peptide I) in L6 myocytes. ( I ) Effects of the inhibitory peptide (peptide I) on glucose uptake in L6 myocytes with or without 100 nM insulin versus the irrelevant one (peptide C). ( J ) Effects of the inhibitory peptide (peptide I) on glucose uptake in primary myocytes from the insulin resistant Zucker fa/fa rat. * p < 0.05; ** p < 0.01; *** p < 0.001.

    Journal: Antioxidants

    Article Title: PIN (Protein Inhibitor of Neuronal Nitric Oxide Synthase) Modulates Glucose Uptake Through NO-Dependent and Independent Mechanisms in Rat Muscle Cells

    doi: 10.3390/antiox15040436

    Figure Lengend Snippet: Effects of PIN silencing and disruption with its interacting partners on glucose uptake in L6 muscle cells. ( A ) Western blotting analysis of PIN under-expression after transfection with PIN and control (C) siRNA. ( B ) Effects of PIN silencing on glucose uptake in L6 myocytes with or without 100 nM insulin. ( C ) Western blotting analysis of GLUT1 expression after transfection with PIN and control (C) siRNA. ( D ) Western blotting analysis of GLUT4 expression after transfection with PIN and control (C) siRNA. ( E ) Colorimetric immunoassay measuring GLUT4 translocation in L6 myocytes after PIN silencing in the presence or not of 100 nM insulin. ( F ) Western blotting analysis of nNOS expression in L6 myocytes after transfection with PIN or control (C) siRNA. ( G ) Effect of PIN silencing on nNOS catalytic activity in the absence of insulin. ( H ) Coimmunoprecipitation of nNOS with PIN in the presence of the control (peptide C) versus the inhibitory peptide (peptide I) in L6 myocytes. ( I ) Effects of the inhibitory peptide (peptide I) on glucose uptake in L6 myocytes with or without 100 nM insulin versus the irrelevant one (peptide C). ( J ) Effects of the inhibitory peptide (peptide I) on glucose uptake in primary myocytes from the insulin resistant Zucker fa/fa rat. * p < 0.05; ** p < 0.01; *** p < 0.001.

    Article Snippet: After saturation with PBS-0.4% BSA during 30 min, cells were incubated with an anti-GLUT4 antibody directed against 13 N-terminus extracellular amino acid of GLUT4 (GT42A, Alpha Diagnostic, San Antonio, TX, USA) overnight.

    Techniques: Disruption, Western Blot, Expressing, Transfection, Control, Translocation Assay, Activity Assay